http://orcid.org/0000-0002-9174-9409
About the Authors
- Teresa Wright
-
Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing
* E-mail: tlwright@alum.mit.edu
Current address: Homology Medicines, Bedford, Massachusetts, United States of America
Affiliation Shire, Lexington, Massachusetts, United States of America
- Aiqun Li
-
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Current address: Sanofi US, Waltham, Massachusetts, United States of America
Affiliation Shire, Lexington, Massachusetts, United States of America
- Jason Lotterhand
-
Roles Investigation, Writing – original draft, Writing – review & editing
Current address: Homology Medicines, Bedford, Massachusetts, United States of America
Affiliation Shire, Lexington, Massachusetts, United States of America
- Anne-Renee Graham
-
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Affiliation Shire, Lexington, Massachusetts, United States of America
- Yan Huang
-
Roles Investigation, Writing – original draft, Writing – review & editing
Affiliation Shire, Lexington, Massachusetts, United States of America
- Nancy Avila
-
Roles Investigation, Writing – original draft, Writing – review & editing
Current address: Homology Medicines, Bedford, Massachusetts, United States of America
Affiliation Shire, Lexington, Massachusetts, United States of America
- Jing Pan
-
Roles Formal analysis, Investigation, Writing – original draft, Writing – review & editing
Affiliation Shire, Lexington, Massachusetts, United States of America
Competing Interests
Teresa Wright, Aiqun Li, Jason Lotterhand and Nancy Avila are former employees of Shire, and Teresa Wright is a current stockholder of Shire. Anne Renee Graham, Yan Huang, and Jing Pan are employees and stockholders of Shire. This does not alter our adherence to PLOS ONE policies on sharing data and materials. Shire has an ongoing clinical development program investigating the use of recombinant human arylsulfatase A for the treatment of patients with late-infantile metachromatic leukodystrophy.